Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

ImmuVen

ImmuVen develops drugs to treat infectious diseases, cancer, and autoimmune disorders.

Acquired by AbbVie on January 01, 2014

Website: https://www.immuven.com

Founded: January 01, 2007

Social:

Add Competitor

Startup	Industry	Description
NeuroX1	Pharmaceuticals & Biotechnology	The new standard in computational neuroscience - NeuroX1 is a computational drug design company bui ...
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
Turn Biotechnologies	Pharmaceuticals & Biotechnology	Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...

View more competitors»

Date	Round	Amount	Investors
May 01, 2012	Grant	$ 1,680,000	National Institute for Allergy and Infectious Disease
Nov 04, 2011	Venture	Undisclosed amount	Serra Ventures
Aug 15, 2011	Seed	$ 250,000

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
David Kranz	Founder	Unknown to Unknown
Patrick Schlievert	Founder	Unknown to Unknown